NYSE:FTV - Fortive Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $77.92
  • Forecasted Upside: 7.66 %
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$72.38
▲ +0.17 (0.24%)
1 month | 3 months | 12 months
Get New Fortive Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FTV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FTV

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$77.92
▲ +7.66% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Fortive in the last 3 months. The average price target is $77.92, with a high forecast of $89.00 and a low forecast of $67.00. The average price target represents a 7.66% upside from the last price of $72.38.
Buy
The current consensus among 12 investment analysts is to buy stock in Fortive. This rating has held steady since November 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 6 buy ratings
  • 8 hold ratings
  • 0 sell ratings
10/25/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 10 hold ratings
  • 0 sell ratings
1/23/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 9 hold ratings
  • 0 sell ratings
4/22/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings
7/21/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 8 hold ratings
  • 0 sell ratings
10/19/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 7 hold ratings
  • 0 sell ratings
1/17/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/18/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/17/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/12/2021Morgan StanleyBoost Price TargetEqual Weight$75.00 ➝ $76.00High
i
4/6/2021BarclaysBoost Price TargetEqual Weight$72.00 ➝ $73.00Medium
i
2/17/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$75.00 ➝ $75.00Low
i
2/5/2021CitigroupBoost Price TargetBuy$83.00 ➝ $85.00Medium
i
1/20/2021Morgan StanleyBoost Price TargetOverweight$74.00 ➝ $75.00Low
i
12/8/2020Wolfe ResearchDowngradeOutperform ➝ Peer Perform$71.00 ➝ $78.00Medium
i
12/4/2020UBS GroupInitiated CoverageBuy$83.00High
i
11/30/2020BarclaysDowngradeOverweight ➝ Equal Weight$72.00High
i
11/12/2020Royal Bank of CanadaLower Price TargetSector Perform$70.00 ➝ $67.00Low
i
10/29/2020Rosenblatt SecuritiesBoost Price TargetNeutral$68.00 ➝ $71.00Low
i
10/28/2020Credit Suisse GroupLower Price TargetOutperform$74.00 ➝ $70.00Low
i
10/28/2020Morgan StanleyLower Price TargetOverweight$75.00 ➝ $74.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
10/19/2020Rosenblatt SecuritiesLower Price TargetNeutral$81.00 ➝ $68.00Low
i
10/16/2020Morgan StanleyLower Price TargetOverweight$88.00 ➝ $75.00Low
i
Rating by Joshua Pokrzywinski at Morgan Stanley
10/14/2020Credit Suisse GroupLower Price TargetOutperform$89.00 ➝ $74.00Low
i
10/7/2020JPMorgan Chase & Co.Boost Price TargetNeutral$78.00 ➝ $81.00Medium
i
10/6/2020CSFBBoost Price TargetOutperform$85.00 ➝ $89.00Low
i
10/6/2020Credit Suisse GroupBoost Price TargetOutperform$85.00 ➝ $89.00Low
i
10/6/2020CitigroupBoost Price TargetBuy$84.00 ➝ $91.00Low
i
9/29/2020Morgan StanleyBoost Price TargetOverweight$83.00 ➝ $88.00Low
i
Rating by Joshua Pokrzywinski at Morgan Stanley
9/10/2020BarclaysReiterated RatingBuy$90.00Medium
i
9/10/2020Bank of AmericaBoost Price TargetBuy$82.00 ➝ $85.00Low
i
9/10/2020Rosenblatt SecuritiesBoost Price TargetNeutral$79.00 ➝ $81.00Medium
i
9/10/2020Credit Suisse GroupBoost Price TargetOutperform$82.00 ➝ $85.00Medium
i
9/2/2020Rosenblatt SecuritiesBoost Price TargetNeutral$77.00 ➝ $79.00Low
i
7/30/2020Royal Bank of CanadaReiterated RatingHold$74.00Medium
i
7/29/2020Credit Suisse GroupBoost Price TargetOutperform$76.00 ➝ $82.00High
i
7/29/2020BarclaysBoost Price TargetOverweight$83.00 ➝ $86.00Medium
i
7/29/2020Rosenblatt SecuritiesBoost Price TargetHold ➝ Neutral$68.00 ➝ $77.00High
i
7/20/2020Royal Bank of CanadaReiterated RatingHold$69.00High
i
6/25/2020Robert W. BairdUpgradeNeutral ➝ Outperform$80.00Medium
i
6/19/2020Morgan StanleyBoost Price TargetOverweight$72.00 ➝ $83.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
6/5/2020Vertical ResearchUpgradeHold ➝ Buy$75.00High
i
5/19/2020Morgan StanleyInitiated CoverageOverweight$72.00Low
i
Rating by Joshua Pokrzywinski at Morgan Stanley
5/6/2020Credit Suisse GroupLower Price TargetMarket Perform ➝ Outperform$85.00 ➝ $71.00Low
i
4/28/2020Robert W. BairdLower Price TargetNeutral$81.00 ➝ $70.00Low
i
4/27/2020CitigroupInitiated CoverageBuy$84.00 ➝ $70.00High
i
Rating by Andrew Kaplowitz at Citigroup Inc.
4/17/2020BarclaysReiterated RatingBuy$73.00High
i
3/9/2020CowenUpgradeUnderperform ➝ Market Perform$70.00High
i
2/25/2020Rosenblatt SecuritiesReiterated RatingHold$78.00High
i
Rating by Scott Graham at Rosenblatt Securities
2/11/2020Raymond JamesDowngradeOutperform ➝ Market PerformLow
i
2/3/2020Rosenblatt SecuritiesReiterated RatingHold$77.00Low
i
Rating by Scott Graham at Rosenblatt Securities
1/9/2020Wolfe ResearchUpgradePeer Perform ➝ OutperformLow
i
12/18/2019Royal Bank of CanadaReiterated RatingHold$79.00Low
i
Rating by Deane Dray at Royal Bank of Canada
12/11/2019Rosenblatt SecuritiesReiterated RatingHold$77.00Medium
i
Rating by Scott Graham at Rosenblatt Securities
12/11/2019Morgan StanleyUpgradeEqual Weight ➝ Overweight$70.00 ➝ $91.00Low
i
Rating by Joshua Pokrzywinski at Morgan Stanley
12/9/2019Credit Suisse GroupUpgradeNeutral ➝ Outperform$82.00Low
i
12/9/2019CitigroupUpgradeNeutral ➝ Buy$76.00 ➝ $84.00Low
i
11/17/2019Rosenblatt SecuritiesReiterated RatingHold$77.00Low
i
11/15/2019JPMorgan Chase & Co.Initiated CoverageNeutral$72.00Medium
i
11/7/2019Rosenblatt SecuritiesInitiated CoverageNeutral$77.00Low
i
10/28/2019ArgusDowngradeBuy ➝ HoldMedium
i
10/25/2019Royal Bank of CanadaSet Price TargetHold$73.00N/A
i
Rating by Deane Dray at Royal Bank of Canada
10/25/2019Credit Suisse GroupBoost Price TargetNeutral$73.00 ➝ $75.00Medium
i
10/15/2019CitigroupLower Price TargetNeutral$86.00 ➝ $76.00High
i
10/11/2019Morgan StanleyLower Price TargetEqual Weight$85.00 ➝ $70.00Low
i
9/18/2019Berenberg BankSet Price TargetBuy$86.00Low
i
Rating by Andrew Buscaglia at Berenberg Bank
9/10/2019Credit Suisse GroupReiterated RatingHold$76.00Low
i
9/5/2019BarclaysLower Price TargetOverweight$89.00 ➝ $84.00High
i
9/5/2019Bank of AmericaLower Price TargetBuy$85.00 ➝ $80.00High
i
8/5/2019Gordon HaskettDowngradeBuy ➝ HoldHigh
i
7/26/2019Raymond JamesSet Price TargetOutperform$88.00 ➝ $84.00Low
i
6/3/2019CowenDowngradeMarket Perform ➝ Underperform$75.00 ➝ $65.00Low
i
5/15/2019Berenberg BankInitiated CoverageBuy ➝ Buy$96.00Low
i
5/8/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$83.48Medium
i
4/30/2019ArgusReiterated RatingBuyLow
i
4/26/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$96.00 ➝ $99.00Medium
i
4/3/2019BarclaysBoost Price TargetOverweight ➝ Overweight$81.00 ➝ $88.00Low
i
2/12/2019William BlairReiterated RatingMarket PerformMedium
i
Rating by B. Drab at William Blair
1/3/2019Credit Suisse GroupReiterated RatingNeutral$86.00 ➝ $78.00High
i
12/18/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$84.00 ➝ $82.00Low
i
Rating by Sawyer Rice at Morgan Stanley
11/21/2018Royal Bank of CanadaReiterated RatingHold$74.00Low
i
10/30/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$90.00 ➝ $84.00Low
i
Rating by Sawyer Rice at Morgan Stanley
10/29/2018SunTrust BanksLower Price TargetBuy ➝ Buy$92.00 ➝ $85.00Low
i
10/26/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$89.00 ➝ $86.00High
i
10/12/2018Credit Suisse GroupInitiated CoverageNeutral$89.00Low
i
10/12/2018Gordon HaskettInitiated CoverageBuyLow
i
10/2/2018Morgan StanleySet Price TargetEqual Weight ➝ Equal Weight$90.00Medium
i
9/13/2018ArgusBoost Price TargetBuy$94.00Medium
i
9/4/2018Wolfe ResearchDowngradeOutperform ➝ Peer PerformLow
i
8/30/2018UBS GroupBoost Price TargetBuy ➝ Buy$86.00 ➝ $93.00Low
i
8/14/2018ArgusBoost Price TargetBuy ➝ Buy$84.00 ➝ $88.00Low
i
7/31/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$80.00 ➝ $85.00Medium
i
7/30/2018CitigroupBoost Price TargetNeutral ➝ Neutral$80.00 ➝ $84.00Low
i
7/27/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$88.00 ➝ $90.00Low
i
6/27/2018Wolfe ResearchInitiated CoverageOutperformMedium
i
3/9/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$84.00High
i
2/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$86.00Low
i
2/12/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$82.00 ➝ $84.00High
i
2/9/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$88.00 ➝ $87.00High
i
2/9/2018Royal Bank of CanadaReiterated RatingNeutral ➝ HoldHigh
i
2/9/2018CitigroupBoost Price TargetNeutral ➝ Neutral$76.00 ➝ $79.00High
i
1/26/2018BMO Capital MarketsReiterated RatingBuy$88.00High
i
1/22/2018UBS GroupInitiated CoverageBuyMedium
i
1/4/2018Royal Bank of CanadaReiterated RatingHold$79.00Medium
i
12/1/2017ArgusUpgradeHold ➝ BuyLow
i
11/15/2017BMO Capital MarketsInitiated CoverageOutperform$82.00N/A
i
10/27/2017SunTrust BanksReiterated RatingBuy$81.00N/A
i
10/27/2017CitigroupBoost Price TargetNeutral$72.00 ➝ $74.00N/A
i
10/27/2017Stifel NicolausBoost Price TargetHold$62.00 ➝ $72.00N/A
i
10/11/2017Royal Bank of CanadaReiterated RatingHold$70.00N/A
i
10/9/2017CitigroupReiterated RatingNeutral$65.00 ➝ $72.00N/A
i
10/2/2017Morgan StanleyReiterated RatingEqual Weight$71.00 ➝ $72.00Low
i
9/15/2017Royal Bank of CanadaReiterated RatingHold$66.00Low
i
7/30/2017Royal Bank of CanadaReiterated RatingSector Perform$65.00 ➝ $66.00Low
i
7/30/2017Stifel NicolausReiterated RatingHold$62.00Low
i
7/11/2017Morgan StanleyReiterated RatingEqual WeightLow
i
5/22/2017OppenheimerReiterated RatingHoldLow
i
Rating by Jim Giannakouros at Oppenheimer Holdings Inc.
5/2/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$61.00 ➝ $65.00Low
i
4/30/2017BarclaysSet Price TargetBuy$66.00Medium
i
Rating by Scott Davis at Barclays PLC
4/19/2017CowenBoost Price TargetMarket Perform$46.00 ➝ $52.00Low
i
3/29/2017SunTrust BanksUpgradeHold ➝ Buy$67.00Low
i
3/24/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$56.00 ➝ $66.00Medium
i
3/23/2017Royal Bank of CanadaInitiated CoverageSector Perform$63.00Low
i
2/7/2017William BlairReiterated RatingMarket PerformN/A
i
Rating by B. Drab at William Blair
1/18/2017OppenheimerInitiated CoverageMarket PerformN/A
i
1/18/2017BarclaysReiterated RatingBuy$65.00N/A
i
1/13/2017Credit Suisse GroupUpgradeNeutral ➝ Outperform$54.00 ➝ $60.00N/A
i
12/15/2016Sanford C. BernsteinReiterated RatingOutperformN/A
i
12/13/2016SunTrust BanksInitiated CoverageHold$57.00N/A
i
9/28/2016The Goldman Sachs GroupInitiated CoverageNeutral$47.00N/A
i
9/23/2016Raymond JamesInitiated CoverageOutperform$58.00N/A
i
9/8/2016ArgusInitiated CoverageHoldN/A
i
8/4/2016CitigroupBoost Price TargetNeutral$51.00 ➝ $52.00N/A
i
8/4/2016UBS GroupReiterated RatingBuyN/A
i
8/4/2016BarclaysReiterated RatingBuyN/A
i
8/4/2016JPMorgan Chase & Co.Reiterated RatingNeutralN/A
i
Rating by Stephen Tusa at JPMorgan Chase & Co.
8/3/2016BarclaysBoost Price TargetOverweight$55.00 ➝ $56.00N/A
i
7/26/2016Bank of AmericaInitiated CoverageBuy$55.00N/A
i
7/14/2016Stifel NicolausInitiated CoverageHoldN/A
i
7/13/2016UBS GroupInitiated CoverageBuy$57.00N/A
i
7/12/2016JPMorgan Chase & Co.Initiated CoverageNeutral$48.00N/A
i
7/9/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Julian Mitchell at Credit Suisse Group AG
7/8/2016Robert W. BairdInitiated CoverageNeutral$52.00N/A
i
7/7/2016Sanford C. BernsteinReiterated RatingOutperform$57.00N/A
i
7/7/2016William BlairReiterated RatingMarket PerformN/A
i
Rating by T. Mulrooney at William Blair
7/6/2016BarclaysInitiated CoverageOverweight$55.00N/A
i
7/5/2016Morgan StanleyInitiated CoverageOverweight$55.00N/A
i
7/5/2016CitigroupInitiated CoverageNeutralN/A
i
7/1/2016CowenInitiated CoverageMarket Perform$46.00N/A
i
6/24/2016Sanford C. BernsteinInitiated CoverageOutperformN/A
i
(Data available from 4/17/2016 forward)
Fortive logo
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, FLUKE NETWORKS, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and PRUFTECHNIK brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Read More

Today's Range

Now: $72.38
$71.95
$73.26

50 Day Range

MA: $69.24
$65.82
$73.56

52 Week Range

Now: $72.38
$52.46
$82.12

Volume

2,314,232 shs

Average Volume

2,287,070 shs

Market Capitalization

$24.47 billion

P/E Ratio

47.31

Dividend Yield

0.39%

Beta

1.14

Frequently Asked Questions

What sell-side analysts currently cover shares of Fortive?

The following equities research analysts have issued stock ratings on Fortive in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Credit Suisse Group AG, CSFB, JPMorgan Chase & Co., Morgan Stanley, Robert W. Baird, Rosenblatt Securities, Royal Bank of Canada, TheStreet, UBS Group AG, Vertical Research, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for FTV.

What is the current price target for Fortive?

13 Wall Street analysts have set twelve-month price targets for Fortive in the last year. Their average twelve-month price target is $77.92, suggesting a possible upside of 7.7%. CSFB has the highest price target set, predicting FTV will reach $89.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $67.00 for Fortive in the next year.
View the latest price targets for FTV.

What is the current consensus analyst rating for Fortive?

Fortive currently has 5 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe FTV will outperform the market and that investors should add to their positions of Fortive.
View the latest ratings for FTV.

What other companies compete with Fortive?

How do I contact Fortive's investor relations team?

Fortive's physical mailing address is 6920 SEAWAY BLVD., EVERETT WA, 98203. The technology company's listed phone number is 425-446-5000 and its investor relations email address is [email protected] The official website for Fortive is www.fortive.com.